Nanodigmbio and MGI Signed a Strategic Partnership Agreement

Shanghai, China, December 25, 2018. Nanodigmbio and MGI signed a strategic partnership agreement at the "2018 Sequencing Technology and Application Summit". The two companies will cooperate to develop the library and targeted capture solution based on MGI sequencing platform, and jointly develop and promote a new ecosystem of NGS industry. 

Wu Qiang, CEO of Nanodigmbio, and Jiang Hui, COO of MGI, signed an agreement on behalf of both parties. In the future, the two parties will carry out multi-dimensional cooperation in product and application development, marketing promotion and other aspects based on the  MGI platforms,  jointly developing sample preparation, targeted sequencing and automation solution.

MGI launched DNBSEQ-G400 (MGISEQ-2000), DNBSEQ-G50 (MGISEQ-200), DNBSEQ-T7, BGISEQ-500, BGISEQ-50 and other sequencers in the global sequencing markets, and has continued to promote all around the world. Nanodigmbio has been cultivating in the targeted sequencing for many years, and NadPrep library solution is perfectly compatible with  MGI platforms. This win-win cooperation enriched total solution for targeted sequencing on multiple platforms. Nanodigmbio will work with MGI to depict a new chapter in the domestic and global market.